The stock rose by 5.6 per cent to Rs 497.5 in morning trade at the BSE.
The shares had touched a high of Rs 510.45 in the opening trade.
Ranbaxy announced that its wholly owned subsidiary Ohm Laboratories will launch Valsartan Tablets and has received approval from the United States Food and Drug Administration with 180-day
Ranbaxy gets FDA nod to sell generic Diovan tablets in US
Sensex up 70 points; defence shares gain
Markets end lower ahead of June F&O expiry
Dilip Shanghvi among Asia's richest self-made billionaires
Pharma M&As to drive Infosys' life sciences biz